SCHEMBL4603597

SCHEMBL4603597

CCCCOC(=O)NC(CCN(C)C)C(=O)OCC(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSL P07711 2/20 0.38
CTSB P07858 2/20 0.38
CTSS P25774 2/20 0.38
CTSK P43235 2/20 0.38
SMN1; SMN2 Q16637 4/20 0.36
NPC1 O15118 2/20 0.36
HPGD P15428 2/20 0.36
RAB9A P51151 2/20 0.36
MAPK1 P28482 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
MCL1 Q07820 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CHRNB2 P17787 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNA4 P43681 1/20 0.36
EPHX1 P07099 1/20 0.36
DNM1 Q05193 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4602209 0.86 MAPK1 (0.40) SMN1; SMN2NPC1HPGDRAB9AMAPK1
SCHEMBL4631031 0.83 ITGB3 (0.42) CTSKSMN1; SMN2NPC1HPGDRAB9A
SCHEMBL4631995 0.82 SMN1; SMN2 (0.39) SMN1; SMN2NPC1HPGDRAB9AMAPK1
SCHEMBL4601990 0.82 CHRNB2 (0.42) SMN1; SMN2NPC1HPGDRAB9AMAPK1
SCHEMBL4632065 0.78 CTSK (0.42) CTSLCTSBCTSSCTSKL3MBTL1
SCHEMBL4632062 0.78 CTSK (0.42) CTSLCTSBCTSSCTSKL3MBTL1
SCHEMBL31023965 0.76 NOD1 (0.42) CTSKSMN1; SMN2NPC1HPGDRAB9A
SCHEMBL4631183 0.74 CTSK (0.46) CTSLCTSBCTSSCTSKL3MBTL1
SCHEMBL4631179 0.74 CTSK (0.46) CTSLCTSBCTSSCTSKL3MBTL1
SCHEMBL31647760 0.73 DNM1 (0.58) L3MBTL1EPHX1DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1924568-A1 QUINAZOLINE DERIVATIVES USEFUL IN CANCER TREATMENT SCHERING CORPORATION (US) 2008-05-28 EP disclosed
EP-1915351-A1 QUINAZOLINE DERIVATIVES USEFUL IN CANCER TREATMENT SCHERING CORPORATION (US) 2008-04-30 EP disclosed
WO-2007011623-A1 QUINAZOLINE DERIVATIVES USEFUL IN CANCER TREATMENT SCHERING CORPORATION (US) 2007-01-25 WO disclosed
WO-2007011618-A1 QUINAZOLINE DERIVATIVES USEFUL IN CANCER TREATMENT SCHERING CORPORATION (US) 2007-01-25 WO disclosed